"Natalizumab treatment reduces microglial activation in the white matter of the MS brain." Neurology - Neuroimmunology Neuroinflammation
6.4
(2019):
e574.
Web. 06 June. 2023.
Advertisement
A peer-reviewed clinical and translational neurology open access journal
